GeminiBio opens new cGMP bioprocess liquid manufacturing facility in California, USA.
This new high-volume liquid production facility significantly increases cGMP bioprocess liquids production capacity.
This new manufacturing facility enables to supply speciality cGMP cell culture media, buffers, water for injection (WFI) and other process fluids in batches of up to 10,000 litres for biotech and life sciences customers.
With the increase of large-scale process fluid production to the existing small and medium-sized capabilities enables cGMP process fluid manufacturing in sizes from 10 litres to 10,000 litres. In addition to the current 500- and 1000-litre formulation tanks, the new facility will consist of one 5000-litre and two 10,000-litre stainless steel tanks.
The production of transformative biotherapies, consisting cell and gene therapies, needs a wide range of upstream and downstream process fluids. The advanced manufacturing capability will further allow to simplify and streamline customer manufacturing flows while improving supply reliability.
Type New Construction